Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT942627RE002
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN14
Additional Details
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a pre-solicitation notice announcing its intention to release a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. This on-ramp is specifically designed to expand participation among small businesses certified under the Small Business Administration 8(a) Program, thereby fostering greater inclusion and competition within the military medical research and development sector.
The OMNIBUS IV contract vehicle, originally awarded through full and open competition, supports a wide range of military medical research and development services. The contract’s base ordering period spans from June 20, 2022, to June 19, 2027, with an option period extending through June 19, 2032. The cumulative ceiling for this unrestricted IDIQ contract is $10 billion, reflecting the significant scale and scope of anticipated research and development activities. To date, over $690 million in task orders have been awarded across 61 task orders, with a substantial portion issued during Fiscal Years 2024–2026. These task orders have been distributed among a diverse set of end users, including the Defense Health Agency Contracting Activity (DHACA), the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences.
The upcoming on-ramp will be set aside exclusively for 8(a) small businesses, aligning with the government’s commitment to supporting socioeconomic programs and expanding opportunities for qualified firms. The government anticipates making multiple new awards under this on-ramp, which will be fully integrated with the existing OMNIBUS IV contract structure. Task orders under this vehicle may be competed under fair opportunity rules, ensuring all contract holders within a market segment have the chance to submit proposals, or may be awarded through exceptions such as set-asides for small businesses or other applicable socioeconomic categories.
The scope of work under NAICS Code 541714—Research and Development in Biotechnology (except Nanobiotechnology)—encompasses a broad array of biotechnology research and development activities relevant to military medical needs. Contractors should expect to deliver innovative solutions and services that advance the Department of Defense’s medical research objectives, with a focus on supporting the health and readiness of military personnel.
This notice, identified by Procurement Identifier HT942627RE002, is not a request for proposals and does not obligate the government to any contractual agreement. It serves to inform potential offerors of the forthcoming opportunity and to provide context regarding the contract vehicle’s history, scope, and anticipated requirements. The anticipated posting of the solicitation has been amended to late November 2026, with no further delays expected.
Interested parties are encouraged to monitor the official notice page on SAM.gov (Opportunity ID: 61fc14ed705b4987bcd93bb0d8ad85c8) for updates and additional details. For further information, prospective offerors may contact Jesse Nisley at [email protected].
This opportunity is particularly well-suited for 8(a) certified small businesses with expertise in biotechnology research and development, seeking to contribute to the Department of Defense’s mission through innovative medical solutions. The contract vehicle’s structure, scope, and history of task order awards underscore its significance and the potential for meaningful engagement over the contract lifecycle.